KFU. Card publication. Efficacy and Safety of Anti-interleukin (IL)-21 in Combination with Liraglutide in Adults Recently Diagnosed with Type 1 Diabetes

- RUS
- 中文
- ES

EFFICACY AND SAFETY OF ANTI-INTERLEUKIN (IL)-21 IN COMBINATION WITH LIRAGLUTIDE IN ADULTS RECENTLY DIAGNOSED WITH TYPE 1 DIABETES

Form of presentation

Conference proceedings in international journals and collections

Year of publication

2020

��

��

Authors, employees of KFU

Gaysina Leylya Rafaelevna, author

Bibliographic description in the original language

Efficacy and Safety of Anti-interleukin (IL)-21 in Combination with Liraglutide in Adults Recently Diagnosed with Type 1 Diabetes // Diabetes, June 01 2020; volume 69 issue Supplement 1

Annotation

Diabetes, June 01 2020; volume 69 issue Supplement 1

Keywords

diabetes

The name of the journal

Diabetes, June 01 2020; volume 69 issue Supplement 1

URL

https://doi.org/10.2337/db20-278-OR

Please use this ID to quote from or refer to the card

https://repository.kpfu.ru/eng/?p_id=237227&p_lang=2

Full metadata record

Field DC	Value	Language
dc.contributor.author	Gaysina Leylya Rafaelevna	ru_RU
dc.date.accessioned	2020-01-01T00:00:00Z	ru_RU
dc.date.available	2020-01-01T00:00:00Z	ru_RU
dc.date.issued	2020	ru_RU
dc.identifier.citation	Efficacy and Safety of Anti-interleukin (IL)-21 in Combination with Liraglutide in Adults Recently Diagnosed with Type 1 Diabetes // Diabetes, June 01 2020; volume 69 issue Supplement 1	ru_RU
dc.identifier.uri	https://repository.kpfu.ru/eng/?p_id=237227&p_lang=2	ru_RU
dc.description.abstract	Diabetes, June 01 2020; volume 69 issue Supplement 1	ru_RU
dc.language.iso	ru	ru_RU
dc.subject		ru_RU
dc.title	Efficacy and Safety of Anti-interleukin (IL)-21 in Combination with Liraglutide in Adults Recently Diagnosed with Type 1 Diabetes	ru_RU
dc.type	Conference proceedings in international journals and collections	ru_RU